<DOC>
	<DOCNO>NCT00649220</DOCNO>
	<brief_summary>To investigate potential reduce concomitant antipsychotic medication use subject moderate dementia Alzheimer 's type , treat memantine .</brief_summary>
	<brief_title>Memantine Antipsychotics Use</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Inclusion criterion : Current diagnosis probable Alzheimer 's disease consistent NINCDSADRDA criterion DSM IV TR criterion Dementia Alzheimer 's type . MRI CT scan support diagnosis DAT without indication relevant CNS disorder . Patients treat acetylcholinesterase inhibitor ( AChEI ) man include . The patient German mothertongue least speak language fluently . Exclusion criterion : Evidence ( include CT/MRI result ) clinically significant central nervous system disease Alzheimer 's disease . Modified Hachinski Ischemia score great 4 screening . Intake medication contraindicate combination memantine . Treatment depot antipsychotic . History severe drug allergy , hypersensitivity , patient know hypersensitivity memantine , amantadine lactose . Known suspected history alcoholism drug abuse within past 10 year . Previous treatment memantine participation investigational study memantine .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>